APcK110
APcK110 is a potent Kit inhibitor that can be used for the research of acute myeloid leukemia (AML). APcK110 induces AML cell apoptosis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1001083-74-4
- Formel: C20H16FN3O2
- Molecular Weight:349.36
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
In Vitro
APcK110 (0-500 nM; 0-72 h) inhibits AML cell viability and proliferation. APcK110 preferentially inhibits KIT mutated BaF3 cell lines[1].
APcK110 (0-500 nM; 30 min) inhibits the phosphorylation of Kit, Stat3, Stat5, and Akt[1].
APcK110 (500 nM; overnight) induces caspase-dependent apoptosis in OCI/AML3 cells[1].
APcK110 (50-500 nM; 7 days) inhibits AML blast colony-forming cell proliferation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:OCI/AML3, HMC1.2, BaF3 and mutant KIT-expressing BaF3 cells
-
Concentration:0-500 nM
-
Incubation Time:0, 24, 48 and 72 h
-
Result:Inhibited proliferation in a dose-dependent manner.
-
Cell Line:OCI/AML3 and HMC1.2
-
Concentration:0, 50, 100, 250 and 500 nM
-
Incubation Time:30 min
-
Result:Showed a dose-dependent inhibition of the phosphorylation of Kit, Stat3, Stat5, and Akt, a downstream effector of phosphatidylinositol 3-kinase.
-
Cell Line:OCI/AML3 cells
-
Concentration:500 nM
-
Incubation Time:Overnight
-
Result:Induced apoptosis by activation of the caspase pathway.
-
Cell Line:OCI/AML3 cells
-
Concentration:500 nM
-
Incubation Time:2 h
-
Result:Showed a shift of cells into sub-G0 following a 2 h incubation.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Eight-weeks-old female NODSCID mice, OCI/AML3 xenograft mouse model[2]
-
Dosage:500 nM
-
Administration:Intraperitoneal injection, every other day for 60 days
-
Result:Survival of compound-treated mice was significantly longer compared with mice injected with PBS.
Chemical Information
-
CAS. Nr. 1001083-74-4
-
Molecular Weight 349.36
-
Formel C20H16FN3O2
-
SMILES
FC1=CC=C(C2=NNC3=NC(C4=CC(OC)=CC(OC)=C4)=CC=C23)C=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Reinheit & Dokumentation
Verweise
[1]. Faderl S, et al. Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells. Cancer Res. 2009 May 1;69(9):3910-7. [Content Brief]
[2]. Faderl S, et al. Kit inhibitor APcK110 extends survival in an AML xenograft mouse model. Invest New Drugs. 2011 Oct;29(5):1094-7. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)